Cryoport introduces HV3 cryogenic system for advanced therapy transport
Cryoport, Inc. has unveiled its latest innovation in temperature-controlled supply chain technology – the Cryoport Express Cryogenic HV3 Shipping System. This development addresses critical challenges in transporting temperature-sensitive biological materials, particularly for cell and gene therapies requiring consistent cryogenic conditions below minus 150°C.